Related references
Note: Only part of the references are listed.The Current Status of Drug Discovery Against the Human Kinome
Richard M. Eglen et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
Identification of Allosteric PIF-Pocket Ligands for PDK1 using NMR-Based Fragment Screening and 1H-15N TROSY Experiments
Brian J. Stockman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
3,5-Diphenylpent-2-enoic Acids as Allosteric Activators of the Protein Kinase PDK1: Structure-Activity Relationships and Thermodynamic Characterization of Binding as Paradigms for PIF-Binding Pocket-Targeting Compounds
Adriana Stroba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1
Valerie Hindie et al.
NATURE CHEMICAL BIOLOGY (2009)
Development of High-Throughput TR-FRET and AlphaScreen (R) Assays for Identification of Potent Inhibitors of PDK1
Zangwei Xu et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Small-Molecule Inhibitors of PDK1
Christian Peifer et al.
CHEMMEDCHEM (2008)
Studies of the Mechanism of Selectivity of Protein Tyrosine Phosphatase 113 (PTP1B) Bidentate Inhibitors Using Molecular Dynamics Simulations and Free Energy Calculations
Lei Fang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A quantitative atlas of mitotic phosphorylation
Noah Dephoure et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
W. De Roock et al.
ANNALS OF ONCOLOGY (2008)
The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module
Natarajan Kannan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds
Matthias Engel et al.
EMBO JOURNAL (2006)
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks
Jesper V. Olsen et al.
CELL (2006)
Steady-state kinetic mechanism of PDK1
Xinxin Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Thermodynamic stability of carbonic anhydrase: Measurements of binding affinity and stoichiometry using ThermoFluor
D Matulis et al.
BIOCHEMISTRY (2005)
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
SF Barnett et al.
BIOCHEMICAL JOURNAL (2005)
PDK1, the master regulator of AGC kinase signal transduction
A Mora et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1
D Komander et al.
STRUCTURE (2004)
Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor
JP Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PDK1 and PKB/Akt: Ideal targets for development of new strategies to structure-based drug design
TK Harris
IUBMB LIFE (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Photochemical preparation of a pyridone containing tetracycle: A Jak protein kinase inhibitor
JE Thompson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
High-density miniaturized thermal shift assays as a general strategy for drug discovery
MW Pantoliano et al.
JOURNAL OF BIOMOLECULAR SCREENING (2001)
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
RM Biondi et al.
EMBO JOURNAL (2001)
A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC-related kinase 2 by PDK1
A Balendran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
RM Biondi et al.
EMBO JOURNAL (2000)
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01
PR Graves et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
